Bank of America’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$85 5959
2025
Q4
$85 Buy
17
+6
+55% +$65 ﹤0.01% 6849
2025
Q3
$110 Sell
11
-10
-48% -$93 ﹤0.01% 7840
2025
Q2
$173 Buy
21
+1
+5% +$9 ﹤0.01% 7867
2025
Q1
$187 Buy
20
+2
+11% +$38 ﹤0.01% 7701
2024
Q4
$410 Sell
18
-27
-60% -$853 ﹤0.01% 7446
2024
Q3
$1.68K Buy
45
+36
+400% +$1.38K ﹤0.01% 7151
2024
Q2
$322 Buy
+9
New +$327 ﹤0.01% 7445
2024
Q1
Sell
-1
Closed -$27 7792
2023
Q4
$27 Buy
+1
New +$35 ﹤0.01% 7602
2023
Q1
Sell
-1
Closed -$93 7862
2022
Q4
$93 Sell
1
-193
-99% -$18.1K ﹤0.01% 7683
2022
Q3
$19K Sell
194
-412
-68% -$57.6K ﹤0.01% 7047
2022
Q2
$102K Buy
606
+365
+151% +$55.5K ﹤0.01% 6447
2022
Q1
$45K Buy
241
+165
+217% +$34.2K ﹤0.01% 7214
2021
Q4
$20K Sell
76
-140
-65% -$36.7K ﹤0.01% 7514
2021
Q3
$63K Sell
216
-810
-79% -$236K ﹤0.01% 6938
2021
Q2
$254K Sell
1,026
-555
-35% -$143K ﹤0.01% 5931
2021
Q1
$453K Buy
1,581
+990
+168% +$395K ﹤0.01% 5449
2020
Q4
$164K Buy
591
+70
+13% +$25.9K ﹤0.01% 5719
2020
Q3
$212K Sell
521
-3,544
-87% -$1.82M ﹤0.01% 5262
2020
Q2
$2.36M Buy
4,065
+3,433
+543% +$1.57M ﹤0.01% 3487
2020
Q1
$144K Buy
+632
New +$110K ﹤0.01% 5297
2019
Q3
Sell
-43
Closed -$1K 7276
2019
Q2
$1K Buy
+43
New +$1.2K ﹤0.01% 7016

Other funds holding CODX

Bank of America's CODX Position: Q1 2026 in Review

Bank of America sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 17 shares — an estimated $85 sold.

Bank of America first reported a position in CODX in Q2 2019 and held it in 21 quarters. The position peaked at $2.36M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Bank of America reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 17 Co-Diagnostics shares in Q1 2026, an estimated $85.
  • Bank of America first reported a position in Co-Diagnostics in Q2 2019 and held it in 21 quarters.
  • Bank of America's Co-Diagnostics position peaked at $2.36M in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.